Hawaii HCR 174: REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A THERAPEUTIC PSILOCYBIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND DEVELOP A LONGTERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN OR PSILOCYBIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.

Status: Referred to HHH, FIN , referral sheet 25 (as of 2021-03-15)

State: Hawaii · Session: 2021 Regular Session · Bill: HCR 174

Subjects: Department of Health, Therapeutic Psilocybin Working Group

Sponsors: GANADEN, KAPELA, MCKELVEY, Marten, WOODSON

View Hawaii HCR 174 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.